Cargando…

Protocatechuic acid attenuates isoproterenol-induced cardiac hypertrophy via downregulation of ROCK1–Sp1–PKCγ axis

Cardiac hypertrophy is an adaptive response of the myocardium to pressure overload or adrenergic agonists. Here, we investigated the protective effects and the regulatory mechanism of protocatechuic acid, a phenolic compound, using a mouse model of isoproterenol-induced cardiac hypertrophy. Our resu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Liyan, Kee, Hae Jin, Han, Xiongyi, Zhao, Tingwei, Kee, Seung-Jung, Jeong, Myung Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405624/ https://www.ncbi.nlm.nih.gov/pubmed/34462460 http://dx.doi.org/10.1038/s41598-021-96761-2

Ejemplares similares

Syringic acid mitigates isoproterenol‐induced cardiac hypertrophy and fibrosis by downregulating Ereg
por: Han, Xiongyi, et al.
Publicado: (2022)

Protocatechuic acid prevents isoproterenol‐induced heart failure in mice by downregulating kynurenine‐3‐monooxygenase
por: Bai, Liyan, et al.
Publicado: (2023)

Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway
por: Zhao, Tingwei, et al.
Publicado: (2021)

Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1
por: Zhao, Tingwei, et al.
Publicado: (2022)

MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA
por: Kim, Gwi Ran, et al.
Publicado: (2021)

Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity
por: Ryu, Yuhee, et al.
Publicado: (2016)

Circular RNA expression in isoproterenol hydrochloride-induced cardiac hypertrophy
por: Yang, Ming-Hui, et al.
Publicado: (2020)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
por: Chakraborty, Songjukta, et al.
Publicado: (2015)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy
por: Gan, Mailin, et al.
Publicado: (2020)

Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy
por: Zheng, Xi, et al.
Publicado: (2022)

Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
por: Zhang, Shijun, et al.
Publicado: (2021)

Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway
por: Al-rasheed, Nouf M, et al.
Publicado: (2015)

Hydrogen (H(2)) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways
por: Zhang, Yaxing, et al.
Publicado: (2016)

Up Regulation of cystathione γ lyase and Hydrogen Sulphide in the Myocardium Inhibits the Progression of Isoproterenol–Caffeine Induced Left Ventricular Hypertrophy in Wistar Kyoto Rats
por: Ahmad, Ashfaq, et al.
Publicado: (2016)

Expression of TMBIM6 in Cancers: The Involvement of Sp1 and PKC
por: Junjappa, Raghu Patil, et al.
Publicado: (2019)

Complex Regulation of PKCβ2 and PDK-1/AKT by ROCK2 in Diabetic Heart
por: Lin, Guorong, et al.
Publicado: (2014)

Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats
por: Yuan, Yonggang, et al.
Publicado: (2017)

Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis
por: Althurwi, Hassan N., et al.
Publicado: (2020)

Amlexanox and Forskolin Prevents Isoproterenol-Induced Cardiomyopathy by Subduing Cardiomyocyte Hypertrophy and Maladaptive Inflammatory Responses
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Identification of serum predictors of n-acetyl-l-cysteine and isoproterenol induced remodelling in cardiac hypertrophy
por: KUBERAPANDIAN, Dharaniyambigai, et al.
Publicado: (2021)

STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways
por: Liu, Fei, et al.
Publicado: (2020)

Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR
por: Yin, Qian, et al.
Publicado: (2016)

Muscle ring finger protein-1 inhibits PKCε activation and prevents cardiomyocyte hypertrophy
por: Arya, Ranjana, et al.
Publicado: (2004)

ΔNp63α suppresses cells invasion by downregulating PKCγ/Rac1 signaling through miR-320a
por: Aljagthmi, Amjad A., et al.
Publicado: (2019)

Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
por: Kee, Hae Jin, et al.
Publicado: (2011)

Preparation and Characterization of Protocatechuic Acid Sulfates
por: Gutierrez-Zetina, Sofia M., et al.
Publicado: (2019)

Gentisic acid attenuates pressure overload‐induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway
por: Sun, Simei, et al.
Publicado: (2018)

Protocatechuic Acid Attenuates Trabecular Bone Loss in Ovariectomized Mice
por: Jang, Seon-A, et al.
Publicado: (2018)

Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling
por: Kim, Jin-Man, et al.
Publicado: (2018)

Xin-Ji-Er-Kang Alleviates Isoproterenol-Induced Myocardial Hypertrophy in Mice through the Nrf2/HO-1 Signaling Pathway
por: Yu, Ting-Ting, et al.
Publicado: (2022)

Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure
por: Galindo, Cristi L, et al.
Publicado: (2009)

A proteomic view of isoproterenol induced cardiac hypertrophy: Prohibitin identified as a potential biomarker in rats
por: Chowdhury, Debabrata, et al.
Publicado: (2013)

miR-139-5p inhibits isoproterenol-induced cardiac hypertrophy by targetting c-Jun
por: Ming, Su, et al.
Publicado: (2018)

Allylmethylsulfide, a Sulfur Compound Derived from Garlic, Attenuates Isoproterenol-Induced Cardiac Hypertrophy in Rats
por: Mohammed, Soheb Anwar, et al.
Publicado: (2020)

Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway
por: Cao, Yuan-Yuan, et al.
Publicado: (2020)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Puerarin attenuates isoproterenol-induced myocardial hypertrophy via inhibition of the Wnt/β-catenin signaling pathway
por: Wang, Xiaoying, et al.
Publicado: (2022)

Effectual Endeavors of Silk Protein Sericin against Isoproterenol Induced Cardiac Toxicity and Hypertrophy in Wistar Rats
por: Ahsan, Farogh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sg8i70qbe5c48t9iv1kgbvq4g0